3 results match your criteria: "Endocrine Research and Clinical Investigation[Affiliation]"
PPAR Res
July 2011
Endocrine Research and Clinical Investigation, Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN 46285, USA.
Peroxisome proliferator-activated receptors (PPARs) play an important role in regulating both glucose and lipid metabolism. Agonists for both PPARgamma and PPARgamma have been used to treat dyslipidemia and hyperglycemia, respectively. In addition to affecting glucose metabolism, PPARgamma agonists also regulate lipid metabolism.
View Article and Find Full Text PDFInt J Obes Relat Metab Disord
February 2002
Endocrine Research and Clinical Investigation, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.
Background: Cocaine- and amphetamine-regulated transcript (CART) is expressed within hypothalamic nuclei implicated in the regulation of feeding behaviour. It is up-regulated by leptin, and CART-derived peptides acutely inhibit food intake.
Objective: The present study was designed to assess the long-term effects of central CART administration on food intake, body weight, plasma levels of glucose, insulin, leptin, free fatty acids and triglycerides, and on fuel utilisation in normal and high-fat-fed obese rats.
Duodecim
March 2002
European Endocrine Research and Clinical Investigation, Wiesingerweg 25, D-20253 Hamburg, Germany.